截至2025年10月31日收盘，骏亚科技（603386）报收于13.0元，较上周的13.99元下跌7.08%。本周，骏 亚科技10月28日盘中最高价报14.28元。10月31日盘中最低价报12.8元。骏亚科技当前最新总市值42.42 亿元，在元件板块市值排名50/57，在两市A股市值排名3737/5163。 本周关注点 交易信息汇总 龙虎榜上榜 沪深交易所2025年10月29日公布的交易公开信息显示，骏亚科技（603386）因有价格涨跌幅限制的日收 盘价格跌幅偏离值达到7%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。 股本股东变化 股东户数变动 近日骏亚科技披露，截至2025年9月30日公司股东户数为1.7万户，较6月30日减少1847.0户，减幅为 9.82%。户均持股数量由上期的1.74万股增加至1.92万股，户均持股市值为26.95万元。 业绩披露要点 财务报告 骏亚科技2025年三季报显示，公司主营收入19.19亿元，同比上升9.36%；归母净利润2171.57万元，同 比上升246.13%；扣非净利润853.01万元，同比上升126.09%；其中2025年第三季度，公司单季度主营收 入6 ...

截至2025年10月31日收盘，精进电动（688280）报收于8.97元，较上周的7.94元上涨12.97%。本周，精 进电动10月31日盘中最高价报9.64元。10月28日盘中最低价报7.86元。精进电动当前最新总市值52.94亿 元，在汽车零部件板块市值排名144/233，在两市A股市值排名3166/5163。 股本股东变化 公司公告汇总 精进电动科技股份有限公司股东上海超越摩尔股权投资基金合伙企业（有限合伙）持有公司38,095,239 股，占总股本6.45%；股东Noble Ray International Limited（诚辉国际）持有54,258,721股，占总股本 9.19%。超越摩尔拟减持不超过8,853,325股（不超过总股本1.50%），诚辉国际拟减持不超过5,902,216 股（不超过总股本1.00%）。减持方式为集中竞价或大宗交易，减持期间为2025年11月19日至2026年2 月18日，股份来源均为IPO前取得，原因为自身资金需求。减持将遵守相关法律法规及承诺，不会导致 公司控制权变更。公司董事会保证公告内容真实、准确、完整。 以上内容为证券之星据公开信息整理，由AI算法生成（网信 ...

截至2025年10月31日收盘，山鹰国际（600567）报收于1.77元，较上周的1.82元下跌2.75%。本周，山 鹰国际10月27日盘中最高价报1.83元。10月31日盘中最低价报1.75元。山鹰国际当前最新总市值102.93 亿元，在造纸板块市值排名3/22，在两市A股市值排名1841/5163。 第九届董事会第三十二次会议审议通过《2025年第三季度报告》、续聘信永中和会计师事务所为2025年 度审计机构、因可转债转股注册资本增至5,815,476,687元、取消监事会、修订《公司章程》及多项治理 制度，并新增日常关联交易预计金额14亿元。 公司将于2025年11月18日召开第三次临时股东大会，审议上述需股东大会批准事项，股权登记日为2025 年11月7日。关联股东福建泰盛实业有限公司及其一致行动人需回避表决《关于新增日常关联交易的议 案》。 本周关注点 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 股本股东变化 截至2025年9月30日，山鹰国际股东户数为196,139户，较6月30日增加7013户，增幅3.71%。户均 ...

Group 1 - The stock price of Jiachi Technology (688708) closed at 70.21 yuan, down 5.8% from last week's 74.53 yuan, with a market cap of 28.085 billion yuan [1] - The highest intraday price this week was 74.92 yuan on September 15, and the lowest was 68.8 yuan on September 18 [1] - Jiachi Technology ranks 11th out of 46 in the aerospace equipment sector and 664th out of 5153 in the A-share market [1] Group 2 - In the first half of 2025, Jiachi Technology reported a revenue of 278.643 million yuan, a year-on-year decrease of 24.33% [2][3] - The net profit attributable to shareholders was 113.202 million yuan, down 46.47% year-on-year [2][3] - Research and development investment increased by 88.78% year-on-year, accounting for 25.47% of total revenue [2][3] Group 3 - CITIC Securities, as the sponsor for Jiachi Technology's IPO, issued a report confirming no major issues or violations were found during the ongoing supervision [2][3] - The company has no significant changes in core competitiveness, and the use of raised funds is compliant [2]

Core Viewpoint - The company, Xinmai Medical, has experienced a decline in revenue and net profit for the first half of 2025, attributed to product pricing and promotional strategy adjustments [2][3]. Group 1: Stock Performance - As of September 12, 2025, Xinmai Medical's stock closed at 108.69 yuan, up 1.77% from the previous week [1]. - The stock reached a high of 114.0 yuan and a low of 107.0 yuan during trading on September 8, 2025 [1]. - The company's current total market capitalization is 13.49 billion yuan, ranking 25th out of 126 in the medical device sector and 1410th out of 5153 in the A-share market [1]. Group 2: Financial Performance - For the first half of 2025, the company reported revenue of 714 million yuan, a year-on-year decrease of 9.24% [2][3]. - The net profit attributable to shareholders was 315 million yuan, down 22.03% year-on-year [2][3]. - Research and development expenses totaled 63.25 million yuan, accounting for 8.85% of revenue [2][3]. Group 3: Corporate Governance - China International Capital Corporation is providing ongoing supervision for Xinmai Medical, confirming effective execution of corporate governance, internal controls, and information disclosure [2]. - The controlling shareholder holds 40.31% of the shares, with no pledges, freezes, or reductions reported [2][3].

Core Viewpoint - Wan Feng Co., Ltd. (603172) has experienced a decline in stock price, with a current market value of 2.145 billion yuan, ranking 160th in the chemical products sector and 4979th in the A-share market [1] Shareholder Changes - As of August 20, 2025, the number of shareholders for Wan Feng Co., Ltd. increased to 8,563, reflecting a growth of 2.65% compared to August 8, 2025. The average number of shares held per shareholder decreased from 16,000 to 15,600 shares, with an average holding value of 271,700 yuan [2] Performance Disclosure Highlights - The mid-year report for 2025 indicates that Wan Feng Co., Ltd. achieved a main revenue of 275 million yuan, representing a year-on-year growth of 17.32%. The net profit attributable to shareholders reached 25.1447 million yuan, up 91.69%, while the net profit excluding non-recurring items was 24.4034 million yuan, also up 91.72%. The second quarter alone saw a net profit of 14.7812 million yuan, marking a 102.66% increase year-on-year. The company's gross margin stands at 26.9%, with a debt ratio of 26.7%, and net cash flow from operating activities increased by 166.10% to 41.5532 million yuan [3] Company Announcement Summary - Wan Feng Co., Ltd. has not declared any profit distribution or capital reserve transfer for the first half of 2025. As of the reporting period, total assets amounted to 1.468 billion yuan, with net assets of 1.074 billion yuan. The weighted average return on net assets is 2.38%, and basic earnings per share are 0.19 yuan. The top ten shareholders include Shaoxing Yufeng Enterprise Management Co., Ltd. with a 43.71% stake and Yu Xingying with an 11.25% stake, both acting in concert with Shaoxing Tianyang Investment. The company reported sales revenue of 243 million yuan from disperse dyes and 30.3765 million yuan from filter cakes, with average prices for disperse dyes and filter cakes declining by 0.31% and 3.12% respectively. The price of key raw material hydrobromic acid increased by 25.08%. The balance of the fundraising account is 16.4 million yuan, with some fundraising projects delayed, including the "Annual Production of 10,000 Tons of Disperse Dye Technological Upgrade Project" postponed to December 2025 and the "Research and Development Center Construction Project" postponed to December 2026. Both the board of directors and the supervisory board have approved the semi-annual report and related proposals [4]

Core Viewpoint - ZhenDe Medical's stock price has shown a slight decline, with a current market capitalization of 6.475 billion yuan, ranking 55th in the medical device sector and 2698th in the A-share market [1] Trading Information Summary - On August 27, ZhenDe Medical recorded a large transaction amounting to 2.32 million yuan [2][7] Shareholder Changes - As of June 30, 2025, the number of shareholders for ZhenDe Medical was 22,600, a decrease of 2,047 or 8.29% from March 31, 2025. The average number of shares held per shareholder increased from 10,800 to 11,800, with an average holding value of 248,400 yuan [3][7] Performance Disclosure Highlights - ZhenDe Medical's mid-year report for 2025 indicated a main revenue of 2.1 billion yuan, a year-on-year increase of 2.83%. However, the net profit attributable to shareholders decreased by 20.7% to 128 million yuan, and the net profit excluding non-recurring items fell by 26.97% to 118 million yuan. In Q2 2025, the main revenue was 1.109 billion yuan, up 2.79% year-on-year, while the net profit attributable to shareholders was 76.52 million yuan, down 12.76% year-on-year [4][7] Company Announcement Summary - ZhenDe Medical will hold a half-year performance briefing on September 11, 2025, from 10:00 to 11:00 at the Shanghai Stock Exchange Roadshow Center. Investors can submit questions from September 4 to September 10, and the company will address commonly asked questions during the meeting [5][7]

Core Points - The stock price of Anjiasi (688581) closed at 75.89 yuan, down 9.21% from last week [1] - The company's market capitalization is currently 6.145 billion yuan, ranking 59th out of 126 in the medical device sector and 2814th out of 5152 in the A-share market [1] Company Performance - In the first half of 2025, the company's operating revenue increased by 14.56% year-on-year [2] - The total profit rose by 2.78% year-on-year, while the net profit attributable to shareholders increased by 1.26% year-on-year [1][2] - The net cash flow from operating activities decreased by 34.90% year-on-year [2] Research and Development - R&D investment grew by 33.29% year-on-year, with its proportion of operating revenue increasing by 1.60 percentage points [2] Compliance and Oversight - During the continuous supervision period, no major issues or violations were found [2]

Core Viewpoint - The company, Times Electric, has shown significant growth in its financial performance for the first half of 2025, with increases in revenue and net profit, alongside a reduction in the number of shareholders and a planned cash dividend distribution [2][4]. Financial Performance - The company's main revenue for the first half of 2025 reached 12.214 billion yuan, representing a year-on-year increase of 17.95% [2][4]. - The net profit attributable to shareholders was 1.672 billion yuan, up 12.93% year-on-year [2][4]. - The net profit excluding non-recurring items was 1.588 billion yuan, reflecting a substantial increase of 37.04% year-on-year [2]. - In Q2 2025, the company achieved a single-quarter revenue of 7.677 billion yuan, a year-on-year increase of 19.88% [2]. - The single-quarter net profit attributable to shareholders was 1.04 billion yuan, up 12.63% year-on-year [2]. - The single-quarter net profit excluding non-recurring items was 991 million yuan, showing a significant increase of 42.02% year-on-year [2]. - The company's debt ratio stood at 36.39%, with investment income recorded at -12.4073 million yuan and financial expenses at -178 million yuan [2]. Shareholder Changes - As of July 31, 2025, the number of shareholders was 20,600, a decrease of 920, or 4.28%, from July 18, 2025 [1][4]. - The average number of shares held per shareholder increased from 40,400 to 42,200 shares, with an average holding value of 1.8466 million yuan [1]. Dividend Announcement - The company plans to distribute a cash dividend of 4.40 yuan (including tax) for every 10 shares to all shareholders [3][4]. - As of June 30, 2025, the total share capital was 1,357,948,412 shares, leading to a total cash dividend distribution of approximately 597.5 million yuan, which accounts for 35.75% of the net profit attributable to shareholders for the first half of 2025 [3].

Group 1 - JinkoSolar's stock price increased by 3.75% this week, closing at 5.54 yuan, with a market cap of 55.429 billion yuan, ranking 5th in the photovoltaic equipment sector [1] - The company provided a total guarantee of 460 million yuan for its subsidiaries to secure financing from financial institutions, with no overdue external guarantees reported [1] - The total amount of guarantees provided by JinkoSolar to its controlling subsidiaries reached 44.929 billion yuan, accounting for 139.06% of the latest audited net assets and 37.10% of total assets [1] Group 2 - JinkoSolar (Feidong) Co., Ltd. applied for a comprehensive credit limit of up to 100 million yuan from Guangfa Bank, with a credit term not exceeding one year [3] - JinkoSolar Middle East DMCC applied for a comprehensive credit limit of up to 360 million yuan (or equivalent foreign currency) from Industrial Bank, with a credit term not exceeding one year [3]